Neuropeptide Y (NPY) related peptides comprise both a neuromodulator (NPY) and hormones (peptide YY (PYY) and pancreatic polypeptide) whose widespread distribution contributes to a diversity of physiological functions. They act in man through four cloned Y receptor subtypes (Y 1 , Y 2 , Y 4 and Y 5 ), members of the class A seven transmembrane domain (7TM) receptor family that signal through pertussis-toxin sensitive G proteins (Michel et al., 1998) . Of these, the Y 1 receptor was the first to be cloned (Krause et al., 1992) and remains the subtype for which the greatest range of selective agonists (Michel et al., 1998) , antagonists (e.g. BIBO3304; Wieland et al., 1998b) and knock-out models (Pedrazzini et al., 1998) are available.
These multiple approaches have defined important roles for central Y 1 receptors in the feeding response to NPY released from hypothalamic arcuate neurones (Pedrazzini et al., 1998; Wieland et al., 1998b) , and NPY-induced anxiolysis (Gibbs et al., 2004) . In the periphery this subtype contributes to sympathetic vasoconstriction (Pedrazzini et al., 1998) and to the inhibition of gastrointestinal secretion (Cox and Tough, 2002) by both neuronal NPY and PYY released from colonic endocrine cells. Y 1 receptor activation also has long term consequences, mediating the neuroproliferation of olfactory progenitors (Hansel et al., 2001 ) and regulating the growth of intestinal epithelial cells (Mannon, 2002) .
Although Y receptors activate a very similar repertoire of G i/o linked second messenger and ion channel responses, the regulatory mechanisms defining the extent of this signalling may differ substantially between the subtypes (Michel et al., 1998) . For example, Y 1 receptor responses rapidly wane after prolonged agonist exposure whether endogenously expressed (Michel, 1994) or transfected (Gicquiaux et al., 2002; Holliday and Cox, 2003) , a process known as desensitization. The Y 1 receptor is also readily sequestered inside the cell when occupied by different ligands (Gicquiaux et al., 2002; Parker et al., 2001; Pheng et al., 2003) . In contrast the Y 2 receptor, which also binds NPY and PYY with high affinity, undergoes relatively less This article has not been copyedited and formatted. The final version may differ from this version. (Gicquiaux et al., 2002; Parker et al., 2001) . Recently Berglund et al. (2003) have provided one explanation for these differences, by demonstrating that agonistoccupied Y 1 receptors interact with the protein β-arrestin2 much more efficiently than the Y 2 subtype. By preventing contact between the stimulated receptor and G protein, the recruitment of β-arrestin family members mediates the desensitization of many 7TM receptors (Gurevich and Gurevich, 2004; Shenoy and Lefkowitz, 2003) . β-arrestins also guide receptor internalization via coated pits (through additional binding sites for phosphoinositides, clathrin and accessory proteins such as AP-2), and they participate as molecular scaffolds for protein kinase cascades signalling to the cytoplasm and nucleus (Shenoy and Lefkowitz, 2003) . They are the best known of an expanding array of partners that bind 7TM receptors directly, other than heterotrimeric G proteins (Brzostowski and Kimmel, 2001) . Understanding how different 7TM receptors regulate these additional interactions is key to defining the full array of signalling pathways available to them, and how the nature of their trafficking influences responses over time.
Since the pioneering studies on the β 2 -adrenoceptor (Bouvier et al., 1988) , the C terminal region has emerged as a crucial domain governing the binding of many 7TM receptors to β-arrestins (Braun et al., 2003; Kisselev et al., 2004; Neuschafer-Rube et al., 2004) and other regulatory proteins (e.g. Xiang et al., 2002) . However, little is known about the molecular determinants that dictate the desensitization and trafficking of different Y receptor subtypes.
Here we address the regulatory role of the Y 1 receptor C terminal domain by comparing the full length receptor with two truncated mutants. We identify a key phosphorylated motif that is essential for its desensitization in biochemical and functional assays, and for β-arrestin2 binding.
Our findings also reveal regulation of constitutive Y 1 receptor internalization by an arrestinindependent mechanism. This article has not been copyedited and formatted. The final version may differ from this version. (10 mCi/ml) was from Amersham Biosciences (Little Chalfont, UK). Peptides, stored as frozen aliquots of aqueous solution, were from Bachem (Merseyside, UK); UK14,304 (5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine, Sigma) was prepared as a 10 mM stock solution (Holliday and Cox, 2003) and the following primers (with bold mutated nucleotides and underlined diagnostic restriction sites as indicated) to introduce stop codons in place of Ser352 (5'-GACTATAGCCATGTGAAGCTTGCATACGGACGTG-3', Hind III) and Thr361 (5'-CGGACGTGTCCAAGTAATATTTGAAGCAGGCAAGCCCG-3',
Ssp I).
The BstX1 / KpnI fragment containing the substitutions was excised and ligated into mammalian expression vectors pTEJ8-rY 1 (which places the native Y 1 receptor cDNA under the control of the ubiquitin C promoter), and pCruz-HAY 1 , in which the rat Y 1 receptor cDNA is modified to include an N terminal HA epitope (YPYDYPDVA), as described (Holliday and Cox, 2003) . These cDNA constructs were each verified by double stranded sequencing.
Cell culture. Cells were maintained in DMEM containing 10 % fetal bovine serum (HEK293 and HCA-7 Colony 1 adenocarcinoma cells, a gift of Dr. S. Kirkland, Imperial College London, UK; Marsh et al., 1993) or DMEM: F12 supplemented with L-glutamine (200 mM) and 10 % heat-inactivated fetal bovine serum (Chinese hamster ovary (CHO) K1 cells, kindly provided by Professor S. Hill, University of Nottingham, UK) as described previously (Holliday and Cox, 2003) . Transfections were performed by calcium phosphate co-precipitation and glycerol (15 %) shock, followed by selection, as appropriate, in 0.8 mg/ml G418 sulfate for 7 -10 days. (Holliday and Cox, 2003) .
Cell responses to vasoactive intestinal polypeptide (VIP), PYY and other agents were measured continuously as changes in short-circuit current I SC , equivalent to the net electrogenic ion transport across the epithelial barrier.
Detection of phosphorylated receptors. For phosphorylation analysis CHO or HEK293
clones were seeded in 6 well plates, and where appropriate they were also transiently transfected with GRK2 or GRK2(K220R) cDNAs (10 µg / well) the next day, 48 h prior to the experiment.
On reaching 80 % confluence, cells were loaded with 50 µCi H 3 PO 4 in phosphate-free Krebs buffer for 1 h at 37°C. Calphostin C (0.5 µM) was included in the buffer for the final 30 min of the loading period where necessary. Peptides and BIBO3304 were subsequently added for the times specified in the text. After two washes in ice-cold phosphate buffered saline, cells were disrupted in immunoprecipitation buffer (RIPA; 50 mM Tris, 100 mM NaCl, 50 mM NaF, 10 mM Na 4 P 2 O 7 , 5 mM EDTA, 1 % Nonidet P40, 0.5 % sodium deoxycholate, 0.1 % SDS, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride, 200 µM activated Na 3 VO 4 , 100 nM okadaic acid, 10 µg/ml leupeptin and aprotinin; pH 8.0) by repeated passage through a 21 G needle. The solubilized extracts were rotated end over end for 2 h at 4°C, clarified by centrifugation (20,000 g, 15 min, 4°C) and equalized for protein content (BCA protein assay, Pierce, Cheshire, UK).
Immunoprecipitations were carried out overnight at 4°C by addition of directly-conjugated anti-HA agarose (clone 3f10), and then the precipitates were washed (4°C, 15 min, rotating) twice with RIPA buffer, twice with high salt wash buffer (50 mM Tris, 500 mM NaCl, 5 mM EDTA, Immunofluorescent analysis was performed as described in detail previously (Sunyach et al., 2003) . Briefly, a vertical stack of 25 -30 fluorescent images was acquired digitally on a Zeiss Axiovert 100 microscope (63x oil objective; Omega Optical excitation and emission filter sets), using Openlab 2.0 (Improvision) to direct a piezo z-axis drive in 0.2 µm steps. The central 15 images (or 10 for studies of GFP-tagged β-arrestin2 localization) for each fluorophore were then deconvolved to remove out-of-focus light (Openlab) and reconstructed in three dimensions 
Results
The distal Y 1 receptor C terminus does not influence G protein signalling. We constructed two truncation mutants of the HA-tagged rat Y1 receptor, in which Ser352
(HAY1S*) and Thr361 (HAY1T*) were replaced by stop codons (Fig. 1) . When stably This article has not been copyedited and formatted. The final version may differ from this version. binding assay. Under buffer conditions (100 mM NaCl, 10 µM GDP) that maximized agonistinduced activation ( Fig. 2A-C) , basal binding was 77.9 ± 7.3 fmol/mg (n = 6) in CHO-HAY1, 81.6 ± 10.6 fmol/mg (n = 7) in CHO-HAY1S* and 68.9 ± 5.1 fmol/mg (n = 9) in CHO-HAY1T* membranes. NPY concentration-response curves were similar in potency for HAY1 (pEC 50 : 8.33
± 0.07, n = 4), HAY1T* (pEC 50 : 7.66 ± 0.06, n = 4) and HAY1S* receptors (pEC 50 : 7.98 ± 0.05, n = 4), while in all cases PYY exhibited lower efficacy than NPY, particularly in CHO-HAY1S* membranes. BIBO3304 prevented 1 µM NPY responses in each of the three clones ( Fig from CHO-HAY1 (pEC 50 : 8.21 ± 0.41; 100 nM maximum 12.1 ± 2.9 %, n = 3) and CHO-HAY1S352* clones (pEC 50 : 9.04 ± 0.38; 100 nM maximum 9.0 ± 1.7 %, n = 3).
HAY1S* receptors are resistant to desensitization. We also investigated GTPγ[ 35 S]
responses in membranes from cells that had been subjected to a short desensitizing pre-treatment with NPY (100 nM, 10 min at 37°C). When compared with controls that had received vehicle alone, pretreated CHO-HAY1 membranes exhibited a substantial reduction in the maximal 1 µM NPY response (Fig. 2D) , with only a small change in the pEC 50 value (Control 8.71 ± 0.05 vs pretreated 8.36 ± 0.11, n = 5) in buffer containing 50 mM NaCl and 1 µM GDP. The absence of This article has not been copyedited and formatted. The final version may differ from this version. 10.0 fmol/mg, n = 5) or an enhanced sensitivity of this binding to BIBO3304 (control 3.8 ± 2.8 % inhibition vs pretreated 3.9 ± 3.7 %, n = 5) confirmed that the first agonist addition had been adequately removed. The attenuated NPY responses in pre-exposed membranes were therefore a consequence of the loss of functionally coupled HAY1 receptors. While an identical reduction in maximal NPY response was observed in pretreated CHO-HAY1T* membranes, agonist stimulation mediated by the HAY1S* receptor was much less affected ( Fig. 2E and F (Holliday and Cox, 2003) .
Basal parameters varied between clones and the parent Colony 1 cell line (mean resistance range of 39.1 -66.5 Ω cm 2 , initial I SC of 6.5 -22.7 µA/cm 2 ; n = 72 -531), as we have previously observed for stably transfected subpopulations (Holliday and Cox, 2003) . Each clone also responded to VIP, an agonist which elevates cAMP, with similar pEC 50 values (8.12 -8.51; n = 3 -69). Peak responses to VIP (30 nM) were sensitive to the loop diuretic piretanide, indicating that much of the I SC response was generated by electrogenic Cl -secretion (Table 2 and This article has not been copyedited and formatted. The final version may differ from this version. (Table 2) , basolateral addition of PYY inhibited VIP-stimulated I SC in C1Y1, C1Y1T* and C1Y1S* clones (Fig. 3) . PYY pEC 50 values (derived from pooled single addition concentration response relationships) were 7.70 ± 0.07 (C1Y1; n = 5 -8), 7.53 ± 0.30 (C1Y1S*; n = 3 -5) and 7.64 ± 0.33 (C1Y1T*; n = 3 -8). The maximal responses to 100 nM PYY (Table 2) were significantly lower in both truncated Y 1 receptor clones compared to C1Y1 epithelial layers, as were maximal I SC decreases to 1 µM UK14,304 (an agonist acting at endogenous α 2 -adrenoceptors, pEC 50 range of 6.95 -7.25 between clones; n = 3 -5; Table 2 ). Thus these Increasing concentrations of PYY initiated markedly more transient reductions in VIP-stimulated I SC in C1Y1 cells (Fig. 4A ). An identical change to a short-lived PYY time-course was also This article has not been copyedited and formatted. The final version may differ from this version. apparent in the C1Y1T* clone (Fig. 4B ), but in contrast responses mediated by the Y 1 (S352*)
receptor remained sustained at the highest PYY concentration investigated (300 nM) and over at least a 10 min period (Fig. 4C) . When normalized as a percentage of the peak response, significant differences between C1Y1S* and either C1Y1 or C1Y1T* 100 nM PYY time-profiles were evident within 4 min of agonist addition (following peak reductions at 2 -3 (C1Y1, C1Y1T*) or 4 min; C1Y1S*) and were maintained thereafter (Fig. 4D) . In contrast to the more sustained phenotype of transfected Y 1 (S352*) receptors, the time-courses of 1 µM UK14,304 responses in the C1Y1S* clone were essentially identical to those in C1Y1 and C1Y1T* cells,
decaying to approximately 50 % of the peak response 10 min after agonist application (Fig. 4E ).
HAY1 receptor phosphorylation is prevented by S352 truncation. We next assessed the incorporation of 32 P i into HAY1 receptors immunoprecipitated with Anti-HA from solubilized extracts of CHO-HAY1 cells (Table 1) No phosphorylated proteins were identified in immunoprecipitates from non-transfected HEK293 cells and only a faint specific band of 71 -100 kD (n = 4) was observed for the HEK-HAY1 clone under basal conditions. This corresponded to the major mature receptor protein detected by Western blotting with either Anti HA or Anti CT/2 (a polyclonal antibody directed against the Y 1 receptor C terminus; Wieland et al., 1998a) . When the cells were stimulated by 1 µM NPY before solubilization and immunoprecipitation the labelling intensity of this band was substantially increased (Fig. 5) , a response which was rapid (maximal for 1 min agonist treatments) and maintained for longer incubation periods (up to 15 min, data not shown). HA-Y 1 receptors were also phosphorylated after PYY addition (1 µM response at 1 min: 2.0 fold over basal, compared to 3.6 fold for 1 µM NPY in the same 2 experiments), and agonist-induced This article has not been copyedited and formatted. The final version may differ from this version. phosphorylation was prevented by 10 min preincubation with 1 µM BIBO3304 (n = 2, data not shown).
We also observed agonist-dependent did not alter HAY1 trafficking alone, but pre-treatment with the antagonist blocked all internalization in response to NPY (Fig. 6 ). Pre-incubation with concanavalin A (0.3 mg/ml) prevented HAY1 receptor endocytosis and significantly restricted the cycling of the transferrin receptor, with punctate transferrin-Texas Red labelling predominantly at or close to the plasma membrane (data not shown).
In contrast to the cell surface distribution of unstimulated HAY1 receptors, live labelling of either HEK-HAY1T* or HEK-HAY1S* cells with Anti HA resulted in substantial internalization of the antibody under basal conditions (Fig. 6) ; in each case the pattern of intracellular localization and transferrin colocalization resembled that for HAY1 receptors stimulated by NPY, but was unaffected by 1 µM BIBO3304 (Fig. 6 ). In the continuous presence of concanavalin A, HAY1T* and HAY1S* receptors labelled with anti HA were exclusively located at the plasma membrane (data not shown). Surprisingly we found that the presence of agonist revealed differences in the behaviour of HAY1T* and HAY1S* receptors. When predominantly intracellular location of HAY1T* receptors did not change. However significantly more HAY1S* receptors were observed at the cell surface, and this redistribution was prevented by co-incubation with 1 µM BIBO3304 (Fig. 6) .
Recruitment of GFP-β-arrestin2 by HAY1 receptors. We transiently expressed GFPtagged β-arrestin2 in the stable HEK-HAY1, HAY1T* and HAY1S* cells to assess its distribution in unstimulated cells, or those treated with NPY for different periods. Under control conditions, diffuse GFP fluorescence was observed throughout the cytoplasm in all three clones (Fig. 7) . 1 µM NPY stimulation for 5 min or 15 min resulted in the appearance of punctate endosomes intensely labelled with GFP in several HEK-HAY1 cells, but after 30 min agonist incubation these structures were less prominent (Fig. 7A) . A similar, though less pronounced, change in distribution was observed after NPY activation of the HAY1T* receptor (Fig. 7B) .
However, no GFP-βarrestin2 translocation could be observed in HAY1S* cells under the same conditions (Fig. 7C ).
Discussion
Here we investigated the role of Y 1 receptor C terminus in regulating its G protein signalling, functional responses and intracellular trafficking. We observed that truncation at Thr361 (HAY1T*) or Ser352 (HAY1S*) did not alter HA-tagged Y 1 receptor-G protein coupling, in contrast to a profound reduction in receptor efficacy after mutation of the more proximal palmitoylation site Cys337 (Holliday and Cox, 2003) . However desensitization of HAY1S* mutant was specifically inhibited, when compared to either HAY1 or HAY1T* receptors, using two complementary approaches. Only HAY1S* responses (measured as NPY- and C1Y1T* clones. We therefore confirmed the effects of S352* truncation on desensitization in an assay where the sequential processes of activation and inactivation can be followed after a single agonist addition (Holliday and Cox, 2003) . Furthermore these functional responses represent the culmination of a signalling cascade involving G i -mediated decreases in cAMP production and a reduction in protein kinase A sensitive basolateral K + and apical Cl -conductances (MacVinish et al., 1993) , for which desensitizing mechanisms may exist at several stages (e.g. stimulation of G i α GTPase activity by regulators of G protein signalling proteins (Roy et al., 2003) . Our data clearly demonstrate that, as the first step of this pathway, Y 1 receptor inactivation is key in determining the pattern and duration of the emerging functional response.
We have demonstrated for the first time that Y 1 receptors are phosphorylated in response to agonist, and have shown that S352* but not T361* truncation inhibited this effect. Although Y 1 receptor signalling can lead to protein kinase C activation, a specific inhibitor (calphostin C) did not inhibit its phosphorylation. Moreover the protein kinase C recognition sites in the Y 1 receptor C terminus (S362; Fig. 1 ) and third intracellular loop (T258) lie outside the critical phosphorylated sequence of four Ser / Thr residues between Ser352 and Lys360 ( Fig. 1) , This article has not been copyedited and formatted. The final version may differ from this version. the more distal C terminus, or those in the intracellular loops for which earlier phosphorylation of this region is required (Ohguro et al., 1993) .
The involvement of β-arrestin2 in Y 1 receptor desensitization was originally suggested by Berglund et al. (2003) , who measured the interaction between the two proteins on NPY stimulation in bioluminescence resonance energy transfer experiments (association t 1/2 of 3 -5 min). We also observed that activated HAY1 and HAY1T*, but not HAY1S* receptors caused the translocation of cytoplasmic GFP-β-arrestin2 to intracellular endosomes. This provides a This article has not been copyedited and formatted. The final version may differ from this version. consistent mechanism (inhibition of phosphorylation and β-arrestin recruitment) for the specific effect of S352* truncation on desensitization in CHO and epithelial cells.
The internalization of NPY-stimulated HAY1 receptors in HEK293 cells is in accordance with previous studies using GFP-tagged Y 1 receptors (Gicquiaux et al., 2002) , or radiolabelled agonists (Parker et al., 2001; Pheng et al., 2003) . As before, the speed of Y 1 receptor endocytosis in response to NPY or PYY, colocalized with labelled intracellular transferrin receptors, indicated a mechanism dependent on clathrin coated pits and the subsequent sorting of receptors to recycling endosomes. However BIBO3304 did not alter Y 1 receptor distribution (predominantly cell surface) in these experiments, beyond its effective blockade of NPY-induced endocytosis. The Y 1 subtype is one of the few reported 7TM receptors to undergo antagonistinduced sequestration (Pheng et al., 2003) , but it appears that this may either be specific for one compound (GR231118), or it reflects the very modest basal internalization that we observed.
Surprisingly unstimulated HAY1S* and HAY1T* receptors underwent substantially enhanced constitutive endocytosis, at least partly to transferrin positive recycling compartments.
Constitutive internalization of 7TM receptors can occur in the absence of agonist-independent activation (α1a-adrenoceptor; Morris et al., 2004) , or as a consequence of it (e.g. CB1 and US28
receptors (Fraile-Ramos et al., 2003; Leterrier et al., 2004) . Although basal activitation and endocytosis of a truncated sst2 somatostatin receptor has also been reported (Schwartkop et al., 1999) , our observations indicate that Y 1 receptor truncation mutants are not constitutively active.
In contrast to the findings of Schwartkop et al. (1999) Zhang et al., 1999) . This would generate a receptor pool protected from agonist exposure and would potentially allow more rapid resensitization (Parent et al., 2001) .
We found that the absence of β-arrestin2 binding to HAY1S* receptors did alter its 
